Latest News & Features
Americas
Eli Lilly has entered into a collaboration agreement with KeyBioscience, a subsidiary of Nordic Bioscience, to commercialise dual amylin calcitonin receptor agonists (DACRAs). 9 June 2017
Americas
The Patent Trial and Appeal Board has handed victory to hedge fund manager Kyle Bass in an inter partes review against a European healthcare company Fresenius Kabi-owned patent. 9 June 2017
Americas
Law firm Foley & Lardner has hired a new partner, Karen Mangasarian, to join its New York office. 9 June 2017
Americas
A district court has sanctioned pharmaceutical company Errant Gene Therapeutics and its counsel for violating the court's protective order. 8 June 2017
Americas
Two thirds of biotech claims challenged in inter partes reviews are directed to methods of treatment, said Brendan O’Malley, partner at Fitzpatrick Cella Harper & Scinto, at a recent industry conference. 8 June 2017
Americas
There has been speculation over whether a patent pool for CRISPR licensing might be created, making it easier for commercial parties to get involved with the technology, according to Larry Coury, senior director of dispute resolution at Regeneron. 8 June 2017
Americas
Bayer has filed a motion for a preliminary injunction against animal health company CAP IM Supply's dog flea treatments. 7 June 2017
article
Erica Pascal of DLA Piper investigates the patentability of machine learning and its outcomes, and the complex issues that may arise. 7 June 2017
Americas
The US Chamber of Commerce and the Association of Corporate Counsel have filed an amicus curiae brief in support of Boehringer Ingelheim Pharmaceuticals in its dispute with the Federal Trade Commission. 6 June 2017
Americas
A district court has granted a stipulated order to the US Food and Drug Administration and Amgen, after they jointly asked the court to end a case centring on paediatric exclusivity for Sensipar. 6 June 2017